Mark E. Stearns
Impact in
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Bone health and treatments
- Cancer Treatment and Pharmacology
Papers in
-
- Ubiquitin and proteasome pathways 9
- Oncology 30
- Bone health and treatments 6
- Cancer Treatment and Pharmacology 5
- Co-authors
- Kenneth D. Tew (7 shared papers)Min Wang (3 shared papers)Min Wang (7 shared papers)K Fudge (4 shared papers)Min Wang (1 shared paper)David L. Brown (4 shared papers)M. Wang (1 shared paper)Nathan G. Dolloff (2 shared papers)
- Journals
- The Prostate (8 papers)The Journal of Cell Biology (4 papers)Clinical & Experimental Metastasis (4 papers)Journal of Cell Science (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Mark E. Stearns
73 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 689
- Oncology 1.1k
- Immunology and Allergy 214
- Cell Biology 363
- Pulmonary and Respiratory Medicine 589
Countries citing papers authored by Mark E. Stearns
This map shows the geographic impact of Mark E. Stearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Stearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Stearns more than expected).
Fields of papers citing papers by Mark E. Stearns
This network shows the impact of papers produced by Mark E. Stearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Stearns. The network helps show where Mark E. Stearns may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Stearns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 167 | |
| 2 | Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. | 1993 | 162 |
| 3 | 1997 | 143 | |
| 4 | 1999 | 141 | |
| 5 | Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. | 1999 | 107 |
| 6 | 1991 | 99 | |
| 7 | 1987 | 96 | |
| 8 | Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. | 1992 | 90 |
| 9 | 1996 | 71 | |
| 10 | 1988 | 67 | |
| 11 | 1982 | 67 | |
| 12 | 1988 | 63 | |
| 13 | Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice. | 1996 | 62 |
| 14 | 2011 | 55 | |
| 15 | 2009 | 55 | |
| 16 | 2010 | 54 | |
| 17 | Decreased expression of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. | 1994 | 54 |
| 18 | 2005 | 52 | |
| 19 | Antimicrotubule effects of estramustine, an antiprostatic tumor drug. | 1985 | 52 |
| 20 | 1987 | 51 |
About Mark E. Stearns
Mark E. Stearns is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Cell Biology, having authored 73 papers that have together received 2.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Microtubule and mitosis dynamics (15 papers), Protease and Inhibitor Mechanisms (13 papers), Ubiquitin and proteasome pathways (9 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Bone health and treatments (6 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Cancer Research (689 citations), Oncology (1.1k citations), Immunology and Allergy (214 citations), Cell Biology (363 citations) and Pulmonary and Respiratory Medicine (589 citations). Mark E. Stearns has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Kenneth D. Tew, Min Wang, Min Wang, K Fudge, Min Wang, David L. Brown, M. Wang, Nathan G. Dolloff, Olimpia Meucci and J S Rhim. Their work appears in journals such as The Prostate, The Journal of Cell Biology, Clinical & Experimental Metastasis, Journal of Cell Science and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.